Suppr超能文献

胰岛素样生长因子II在人肾上腺嗜铬细胞瘤和肾母细胞瘤中的表达:mRNA和蛋白质水平的表达情况

Insulin-like growth factor II in human adrenal pheochromocytomas and Wilms tumors: expression at the mRNA and protein level.

作者信息

Haselbacher G K, Irminger J C, Zapf J, Ziegler W H, Humbel R E

出版信息

Proc Natl Acad Sci U S A. 1987 Feb;84(4):1104-6. doi: 10.1073/pnas.84.4.1104.

Abstract

Two forms of insulin-like growth factor (IGF) II with molecular masses of 10 and 7.5 kDa, respectively, were found in tumor tissue from human adrenal pheochromocytomas. The tumors contained 5.3-7.1 micrograms of immunoreactive IGF-II per g of tissue, which is about 20 times more than in adrenal medulla. The total bioactive IGF in the pheochromocytomas exceeded that in normal liver or kidney, which contained only the 7.5-kDa IGF-II species, by a factor of approximately equal to 100. By contrast, the amount of IGF-I was just measurable and did not vary significantly between tumor and normal tissue. The high amounts of IGF-II in the pheochromocytomas were not reflected, however, by a corresponding increase of mRNA. The opposite situation was found in Wilms tumors, where IGF-II content was in the same range as in nontumor tissues despite increased expression of IGF-II mRNA.

摘要

在人肾上腺嗜铬细胞瘤的肿瘤组织中发现了两种胰岛素样生长因子(IGF)II,分子量分别为10 kDa和7.5 kDa。肿瘤组织每克含有5.3 - 7.1微克免疫反应性IGF-II,这比肾上腺髓质中的含量约高20倍。嗜铬细胞瘤中的总生物活性IGF超过正常肝脏或肾脏(仅含有7.5 kDa的IGF-II)约100倍。相比之下,IGF-I的含量仅可检测到,且在肿瘤组织和正常组织之间无显著差异。然而,嗜铬细胞瘤中大量的IGF-II并未表现为相应的mRNA增加。在肾母细胞瘤中发现了相反的情况,尽管IGF-II mRNA表达增加,但其IGF-II含量与非肿瘤组织处于相同范围。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f8b/304370/de7dbfbc414e/pnas00269-0211-a.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验